Drugs with this side effect as MedDRA Preferred Term
- 17-hydroxyprogesterone
- 4-AP
- 5-ASA
- Infection: postmarketing, 3.2% - 9%
- 5-FU
- 5-aminolevulinic acid
- 5-aza-2'-deoxycytidine
- 5-azacytidine
- 8-MOP
- A77 1726
- ACTH(1-39
- ALX 111
- Almeta
- Anidulafungin
- BCNU
- BPTI
- Bivalirudin
- CGP 19835A
- Cancidas
- Carfilzomib
- Enfuvirtide
- Eptifibatide
- FAMP
- FK463
- FTY720
- FdUrd
- Fe(III
- Glat copolymer
- Goserelin
- Histrelin
- Humalog
- ICI 182,780
- Implanon
- Insulin
- K779
- L-Dmp
- LY146032
- Infection: postmarketing, 48.3% - 54.2%
- Lantus
- Leuprorelin
- Lisinopril
- Lovaza
- Lutalyse
- Lyxumia
- MDV3100
- Metrodin
- N-carbamylglutamate
- NTBC
- NovoLog
- NuvaRing
- Nuvocid
- Octreotide
- Oestrogen
- PCI-32765
- PEP005
- PGE1
- Photofrin
- Photofrin II
- Promacta
- Refludan
- Revasc
- Romidepsin
- SU5416
- Sativex
- Saxagliptin
- Supremon
- TMC435
- TR-700
- Triptorelin
- Trisequens
- UDCA
- VACV
- Vallergan
- Vancocine
- Westcort
- Infection
- Secondary infection
- abacavir
- abiraterone
- acamprosate
- acitretin
- aclidinium bromide
- actinomycin D
- afatinib
- agomelatine
- alclometasone
- alendronate
- alfuzosin
- allopurinol
- alosetron
- alprazolam
- ambrisentan
- amcinonide
- amiodarone
- ammonia
- amoxicillin
- amphetamine
- amphotericin B
- amsacrine
- anagrelide
- anastrozole
- anthracycline
- Infection
- Secondary infection
- apraclonidine
- aprepitant
- argatroban
- aripiprazole
- arsenic
- arsenic trioxide
- articaine
- atazanavir
- atomoxetine
- atorvastatin
- atovaquone
- avanafil
- azathioprine
- Infection: 1% - 20%
- Secondary infection
- azelastine
- azithromycin
- baclofen
- balsalazide
- beclomethasone
- beclomethasone dipropionate
- beclomethasone monopropionate
- belinostat
- benazepril
- benazeprilat
- bendamustine
- Infection: 0.699% - 5.88%
- betamethasone dipropionate
- Infection
- Secondary infection
- betamethasone valerate
- betaxolol
- bexarotene
- Infection: common, 0% - 22.6%
- bezafibrate
- bicalutamide
- bimatoprost
- Infection: uncommon, 0.4% - 1.3%
- bisoprolol
- bleomycin hydrochloride
- boceprevir
- bortezomib
- Infection: 0.301% - 20.8%
- bosentan
- bosutinib
- brimonidine
- brinzolamide
- bromcresol green
- bromocriptine
- budesonide
- bupivacaine
- buprenorphine
- bupropion
- Infection: rare, 4.7% - 9%
- busulfan
- cabazitaxel
- cabozantinib
- caffeine
- canagliflozin
- Infection
- Recurrent infection
- candesartan cilexetil
- capecitabine
- capsaicin
- carbamazepine
- carbimazole
- carboplatin
- carnitine
- carvedilol
- cefepime
- ceftriaxone
- celecoxib
- cetirizine
- cevimeline
- chlorambucil
- chloride
- chlorpromazine
- ciclesonide
- cidofovir
- cilostazol
- cinacalcet
- cisplatin
- citalopram
- Infection: infrequent, uncommon
- cladribine
- Infection: very common, 28%
- clarithromycin
- Infection: postmarketing, common, 3% - 9.4%
- clobazam
- clobetasol
- Infection: 10% - 14.2%
- Secondary infection
- clobetasol propionate
- clobetasone butyrate
- Infection
- Secondary infection
- clocortolone
- clodronate
- clofarabine
- clonazepam
- clonidine
- clopidogrel
- clozapine
- colesevelam
- colestimide
- conivaptan
- conjugated estrogens
- copolymer 1
- cortisol
- Infection
- Secondary infection
- cosyntropin
- crizotinib
- cyanocobalamin
- cyclophosphamide
- cytarabine
- cytokinin
- d-telaprevir
- dabigatran etexilate
- dabrafenib
- dalbavancin
- dalteparin
- dapagliflozin
- darifenacin
- dasatinib
- Infection: postmarketing, 0% - 15%
- deferasirox
- deferiprone
- deferoxamine
- delamanid
- delavirdine
- demethyl
- deprenyl
- desflurane
- desloratadine
- desmopressin
- desonide
- Infection: 19.6% - 20.4%
- Secondary infection
- desoximetasone
- dexamethasone
- Infection
- Secondary infection
- dexmedetomidine
- dexrazoxane
- dextran
- diatrizoate
- diazepam
- diclofenac
- didanosine
- diflorasone diacetate
- diltiazem
- docetaxel
- Infection: postmarketing, 0% - 37%
- donepezil
- doripenem
- Infection: common, 0% - 2%
- doxazosin
- doxepin
- doxercalciferol
- doxorubicin
- Infection: postmarketing, common, 0% - 25.9%
- Secondary infection
- doxycycline
- doxycycline hyclate
- duloxetine
- empagliflozin
- emtricitabine
- Infection: 44%
- Infection mixed: postmarketing
- entecavir
- epinastine
- eplerenone
- eribulin
- erlotinib
- ertapenem
- eslicarbazepine
- esomeprazole magnesium
- estradiol
- etidronate
- etodolac
- etoposide
- etoposide phosphate
- etoricoxib
- etravirine
- everolimus
- exemestane
- exenatide
- ezetimibe
- famciclovir
- famotidine
- febuxostat
- felbamate
- fenofibrate
- fenofibric acid
- fentanyl
- fesoterodine
- fexofenadine
- finasteride
- fludarabine
- fludrocortisone
- fludrocortisone acetate
- flumethasone
- flunisolide
- fluocinolone
- fluocinolone acetonide
- Infection
- Secondary infection
- fluocinonide
- fluoxetine
- flurandrenolone
- flurbiprofen
- fluticasone
- Infection: postmarketing
- Secondary infection
- fluticasone furoate
- fluticasone propionate
- Infection
- Secondary infection
- fluticasone/salmeterol
- fluvastatin
- fluvoxamine
- Infection: infrequent, 11.3%
- fondaparinux
- formoterol
- fosaprepitant
- fosaprepitant dimeglumine
- foscarnet
- fosfomycin
- fosfomycin trometamol
- fosinopril
- fosphenytoin
- gabapentin
- gadobenate dimeglumine
- gadobutrol
- gadofosveset
- ganciclovir
- gatifloxacin
- gefitinib
- gemcitabine
- gliclazide
- glucose solution
- glutamine
- glycopyrrolate
- granisetron
- halcinonide
- Secondary infection
- Infection
- halobetasol
- heparin
- histamine
- hydrocortisone butyrate
- hydromorphone
- hydroxybutyrate
- hydroxyl radicals
- hydroxyurea
- ibandronate
- ibuprofen
- icodextrin
- idarubicin
- ifosfamide
- Infection: postmarketing, 8%
- iloperidone
- imatinib
- Infection: postmarketing, rare, 0% - 53.3%
- imipramine
- imiquimod
- Infection: postmarketing, uncommon, common, 0% - 1.4%
- indacaterol
- indapamide
- insulin detemir
- iopamidol
- ioxilan
- ipratropium bromide
- irbesartan
- irinotecan
- Infection: postmarketing, 0% - 33.6%
- iron sucrose
- isosorbide-5-mononitrate
- itraconazole
- ivacaftor
- ixabepilone
- ketoprofen
- ketorolac
- ketorolac tromethamine
- ketotifen
- lamivudine
- lamotrigine
- Infection: infrequent, 2% - 20%
- lansoprazole
- lapatinib
- lasofoxifene
- leflunomide
- Infection: postmarketing, rare, 0% - 4%
- lenalidomide
- Infection: postmarketing, common
- letrozole
- leucovorin
- leuprorelin acetate
- levetiracetam
- levonorgestrel
- linaclotide
- linagliptin
- liraglutide
- lisuride
- lithium carbonate
- lomitapide
- lomustine
- lorazepam
- Infection: infrequent, 0.769%
- lorcaserin
- losartan
- lovastatin
- lurasidone
- mTHPC
- macitentan
- mannitol
- maprotiline
- maraviroc
- medroxyprogesterone
- medroxyprogesterone acetate
- Infection: postmarketing, 0.2 - 1.0%
- mefenamic acid
- megestrol
- megestrol acetate
- melatonin
- meloxicam
- melphalan
- memantine
- meropenem
- metformin
- methotrexate
- methyl aminolevulinate
- methyldopa
- methylphenidate
- Infection: postmarketing, 2.2% - 5.8%
- methylprednisolone
- Infection
- Secondary infection
- methylprednisolone sodium succinate
- metronidazole
- miconazole
- mifepristone
- milnacipran
- minocycline
- mirabegron
- mirtazapine
- misoprostol
- mitotane
- mitoxantrone
- modafinil
- mometasone
- Infection
- Secondary infection
- mometasone furoate
- montelukast
- morphine
- moxonidine
- mycophenolate mofetil
- mycophenolic acid
- Infection: postmarketing, 18.2% - 37%
- nabilone
- naltrexone
- naproxen
- Infection: postmarketing, 1-3% - 3-9%
- naratriptan
- Infection: infrequent, frequent
- nefazodone
- nelarabine
- Infection: postmarketing, 1% - 9%
- neomycin
- nicardipine
- nicorandil
- nilotinib
- nitazoxanide
- nitrazepam
- nitrogen mustard
- nitroglycerin
- nizatidine
- ofatumumab
- ofloxacin
- olanzapine
- olmesartan
- olodaterol
- olopatadine
- olsalazine
- omeprazole
- orlistat
- oseltamivir
- oxaliplatin
- Infection: very common, 0% - 31.6%
- oxaprozin
- oxcarbazepine
- oxybutynin
- oxycodone
- paclitaxel
- Infection: postmarketing, rare, uncommon, very common, 0.249% - 38%
- paliperidone
- palonosetron
- pamidronate
- Infection: postmarketing, 0% - 32.3%
- pantoprazole
- parecoxib
- paricalcitol
- paroxetine
- Infection: infrequent, uncommon, 3% - 8%
- pazopanib
- pemetrexed
- Infection: common, 0% - 11%
- pentamidine
- pentosan polysulfate
- pentostatin
- pentoxifylline
- perampanel
- pergolide
- perphenazine
- phenytoin
- pilocarpine
- pimecrolimus
- pioglitazone
- pirfenidone
- piroxicam
- pixantrone
- pomalidomide
- ponatinib
- posaconazole
- potassium
- pramipexole
- pravastatin
- prednicarbate
- prednisolone phosphate
- prednisone
- pregabalin
- procarbazine
- prochlorperazine
- progesterone
- propafenone
- propericiazine
- propranolol
- prostacyclin
- prucalopride
- quetiapine
- Infection: postmarketing, 2%
- quinapril
- raloxifene
- raltegravir
- raltitrexed
- rapamycin
- rasagiline
- reboxetine
- regorafenib
- rescinnamine
- retigabine
- retinoic acid
- Infection: postmarketing, uncommon, 58%
- Secondary infection
- rifapentine
- rifaximin
- rilpivirine
- riluzole
- rimonabant
- riociguat
- risedronate
- risperidone
- rivaroxaban
- rivastigmine
- rofecoxib
- roflumilast
- ropinirole
- ropivacaine
- rosiglitazone
- rosuvastatin
- rotigotine
- rufinamide
- ruxolitinib
- salbutamol
- Infection: postmarketing, 0% - 1.7%
- salmeterol
- salmon calcitonin acetate
- samarium
- saquinavir
- sevelamer hydrochloride
- sibutramine
- sildenafil
- simvastatin
- sitagliptin
- sitaxsentan
- sodium
- sodium ferric gluconate
- sodium iothalamate
- sofosbuvir
- solifenacin
- sorafenib
- Infection: postmarketing, very common
- sotalol
- sugammadex
- sulfacetamide
- sulfasalazine
- sumatriptan
- Infection: rare, 0.6% - 1.4%
- sunitinib
- suvorexant
- tacrolimus
- Infection: postmarketing, 1% - 76%
- tadalafil
- tafamidis
- tamoxifen
- tamsulosin
- tapentadol
- technetium-99m
- teduglutide
- tegaserod
- telmisartan
- temozolomide
- Infection: postmarketing, common
- temsirolimus
- teniposide
- terbinafine
- testosterone
- tetrahydrobiopterin
- thalidomide
- Infection: postmarketing, 0% - 59.4%
- theophylline
- thiotepa
- tiagabine
- tigecycline
- Infection: common, 5% - 8.3%
- timolol
- tiotropium
- tipranavir
- tizanidine
- tofacitinib
- tolcapone
- Infection: common, frequent
- tolterodine
- topiramate
- Infection: postmarketing, 0% - 14%
- topotecan
- Infection: very common, 0% - 43%
- trabectedin
- tramadol
- Infection: postmarketing, uncommon
- trametinib
- trandolapril
- travoprost
- treprostinil
- triamcinolone
- Infection
- Secondary infection
- triamcinolone acetonide
- Infection: 0% - 7.44%
- Secondary infection
- tris
- trospium chloride
- umeclidinium
- ustekinumab
- v 1784
- Infection: postmarketing, 0% - 24.7%
- valdecoxib
- valganciclovir
- valproate
- valsartan
- vandetanib
- vardenafil
- varenicline
- vemurafenib
- venlafaxine
- verapamil
- vigabatrin
- vildagliptin
- vincristine
- vinflunine
- vinorelbine
- Infection: postmarketing, 0% - 5%
- voriconazole
- vorinostat
- warfarin
- zafirlukast
- zalcitabine
- zanamivir
- ziconotide
- zidovudine/lamivudine
- ziprasidone
- zoledronic acid
- Infection: postmarketing, 4% - 12%
- zolmitriptan
- zolpidem
- Infection: postmarketing, infrequent, 1%
- zonisamide
- zopiclone
|
Drugs with this indication
|